DJIA 16,596.64 -58.13 -0.35%
NASDAQ 4,815.88 3.17 0.07%
S&P 500 1,980.09 -7.57 -0.38%
market minute promo

ULTRAGENYX PHARMAC (NASDAQ: RARE)

114.01 5.91 (5.47%)

Quote as of


company name or ticker

Recent Quotes

RARE $114.01 5.47%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.03
Previous Close $108.10
Daily Range $106.24 - $114.83
52-Week Range $38.01 - $137.05
Market Cap $4.4B
P/E Ratio -43.94
Dividend (Yield) $0.00 (0.0%)
Volume 376,523
Average Daily Volume 528,704
Current FY EPS -$3.29

Sector

Industry

ULTRAGENYX PHARMAC (RARE) Description

ULTRAGENYX PHARMAC Website: http://www.ultragenyx.com/

News & Commentary

Why Ultragenyx Pharmaceutical Inc. Stock Slumped

Ultragenyx shares aren't looking so "ultra" today after the company announced its intention to sell shares of common stock. Find out what this means for investors.

Ultragenyx Pharmaceutical's (RARE) CEO Emil Kakkis on Q2 2015 Results - Earnings Call Transcript

After-Hours Earnings Report for August 13, 2015 : AMAT, JWN, KING, RARE, AZPN, WX, CIB, DAR, YY, PC

After-Hours Earnings Report for August 13, 2015 : AMAT, JWN, KING, RARE, AZPN, WX, CIB, DAR, YY, PCTY, GLOB, LOCO

This Week's First IPO: Global Blood Therapeutics Developing Drugs For Diseases Affecting Few

Ultragenyx Announces Initiation of Phase 2 Study of Recombinant Human Beta-Glucuronidase in Patients

Ultragenyx Announces Initiation of Phase 2 Study of Recombinant Human Beta-Glucuronidase in Patients Under Five Years Old With Mucopolysaccharidosis 7, FDA Fast Tracks rhGUS Program In MPS 7

Ultragenyx Downgraded At Morgan Stanley, Valuation 'Stretched' And Pipeline Faces Execution Risk

First Week of September 18th Options Trading For Ultragenyx Pharmaceutical (RARE)

Benzinga's Top #PreMarket Losers

Stocks Hitting 52-Week Highs

Ultragenyx Releases Positive Interim 40-Week Bone Treatment Data From Ongoing Pediatric Phase 2 Stud

Ultragenyx Releases Positive Interim 40-Week Bone Treatment Data From Ongoing Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia

First Week of RARE February 2016 Options Trading

See More RARE News...